CAG is always recruiting for members interested to undertake training to become a GRADE (Grading of Recommendations Assessment, Development and Evaluation) and guideline methodologist for the development of CAG Clinical Practice Guidelines. Learn more about this opportunity here.
Clinical Practice Guidelines (CPG) and Consensus Reports are developed by the appropriate/pertinent committees (Practice Affairs, Endoscopy, Pediatrics, Hepatobiliary, Ethics) or individual members with a particular interest, on behalf of the Canadian Association of Gastroenterology (CAG) in order to outline the clinical approach to management problems or training issues. After preparation, based on a review of the literature, each guideline/consensus report is made available to the CAG membership for review. Finally, the guideline/consensus report is presented to the CAG Governing Board for further review and final approval.
CPGs and Consensus Reports are intended to give an understanding of a clinical problem and outline one or more preferred approaches to investigation and management of the problem. While CPGs are intended to be useful to all physicians, it is recognized that specialists may rely less on practice guidelines than those in more general practice. These guidelines are intended to give a practical approach to a problem based on the current literature, but are not intended to be state-of-the-art reviews with extensive references. Consensus reports are derived in line with accepted literature surrounding the process and production of Consensus documents, and as such, provide an extensive and complete review of the literature. More recently completed Consensus Reports have been developed in accordance with literature on accepted consensus process.
CPGs and Consensus Reports are developed to be of assistance to practicing clinicians and are not intended to be the only approach to the management of clinical problems, nor are they intended to be considered as a ‘standard of care’. The CAG recognizes that clinical circumstances may at times justify an approach different from that outlined in a practice guideline. It is also recognized that new developments in medical research and clinical practice may require subsequent changes to the practice guideline.
Category | Year | Title | Publication Type | Document |
---|---|---|---|---|
Endoscopy | 1997 | Endoscopic Retrograde Cholangiopancreatography Credentialling 1997 | Guideline | View/Download |
Endoscopy | 1997 | Informed Consent for GI endoscopy | Guideline | View/Download |
Endoscopy | 2006 | Colonoscopy Preparation | Guideline | View/Download |
Endoscopy | 2007 | Endoscopic Priveledges | Guideline | View/Download |
Endoscopy | 2008 | Colonoscopy Credentialling | Guideline | View/Download |
Lower GI | 2008 | Endoscopic Retrograde Cholangiopancreatography Credentialling 2008 | Guideline | View/Download |
Endoscopy | 2008 | Esophagogastroduodenoscopy Credentialling | Guideline | View/Download |
Endoscopy | 2008 | Flexible Sigmoidoscopy Credentialling | Guideline | View/Download |
Endoscopy | 2008 | Propofol use during Endoscopy | Position Paper | View/Download |
Endoscopy | 2012 | Safety & Quality Indicators in Endoscopy | Guideline | View/Download |
Endoscopy | 2017 | Capsule Endoscopy | Guideline | View/Download |
Endoscopy | 2017 | The Impact of Simethicone on Endoscope Reprocessing | Position Paper | View/Download |
Endoscopy | 2017 | CAG Position Statement: The Impact of Simethicone on Endoscope Reprocessing | Position Paper | View/Download |
General | 2018 | Statement on Link Between PPI and Gastric Cancer | Position Paper | View/Download |
General | 2018 | Cannabis | Position Paper | View/Download |
Liver | 1998 | Evaluation of abnormal liver enzyme tests | Guideline | View/Download |
Liver | 2000 | Liver Biopsy | Guideline | View/Download |
Liver | 2012 | Management of chronic Hep B | Guideline | View/Download |
Liver | 2015 | Management of chronic Hep C consensus update | Guideline | View/Download |
Lower GI | 2001 | Crohn's: Use of Infliximab | Guideline | View/Download |
Lower GI | 2002 | Anti-TNF Therapy | Position Paper | View/Download |
Lower GI | 2004 | Colon Cancer Screening, 2004 | Guideline | View/Download |
Lower GI | 2004 | Crohn's: Use of Infliximab | Guideline | View/Download |
Lower GI | 2005 | CDAD and PPI Therapy | Position Paper | View/Download |
Lower GI | 2009 | Crohn's: Use of tumour necrosis factor | Guideline | View/Download |
Lower GI | 2009 | FDA Safety Alert: OSP | Position Paper | View/Download |
Lower GI | 2010 | Colon Cancer Screening, 2010 | Guideline | View/Download |
Lower GI | 2012 | IBD: UC in severe hosptialized patients | Guideline | View/Download |
Lower GI | 2013 | IBD: SEBS | Position Paper | View/Download |
Lower GI | 2014 | IBD: Venous Thromboembolism | Guideline | View/Download |
Lower GI | 2014 | IBD: Thiopurines | Position Paper | View/Download |
Lower GI | 2014 | Fecal Microbiota Transplant Therapy | Position Paper | View/Download |
Lower GI | 2015 | IBD: Dysplasia | Guideline | View/Download |
Lower GI | 2015 | IBD: UC in mild-severe outpatients | Guideline | View/Download |
Lower GI | 2016 | IBD: Pregnancy | Guideline | View/Download |
Lower GI | 2018 | Fistulizing Crohn's Disease | Guideline | View/Download |
Lower GI | 2018 | Screening for Colorectal Cancer | Guideline | View/Download |
Lower GI | 2019 | Management of Irritable Bowel Syndrome (IBS) | Guideline | View/Download |
Non-Medical | 2000 | Critical approach to CPGs | Guideline | View/Download |
Non-Medical | 2002 | Industry Interaction | Position Paper | View/Download |
Non-Medical | 2006 | Wait Times | Guideline | View/Download |
Upper GI | 1998 | Dysphagia, 1998 | Guideline | View/Download |
Upper GI | 1998 | GERD, 1998 | Guideline | View/Download |
Upper GI | 1998 | H. pylori (adults), 1998 | Guideline | View/Download |
Upper GI | 1998 | Non-Cardiac Chest Pain | Guideline | View/Download |
Upper GI | 1999 | Antibiotic Prophylaxis for Endoscopy | Guideline | View/Download |
Upper GI | 1999 | H. pylori (adults), 1999 | Guideline | View/Download |
Upper GI | 1999 | H. pylori (peds) | Guideline | View/Download |
Upper GI | 2003 | Non-Variceal Upper GI Bleeding (adults) 2003 | Guideline | View/Download |
Upper GI | 2004 | H. pylori (adults), 2004 | Guideline | View/Download |
Upper GI | 2004 | Non-Variceal Upper GI Bleeding algorithm (adults) | Guideline | View/Download |
Upper GI | 2004 | Non-Variceal Upper GI Bleeding (peds) | Position Paper | View/Download |
Upper GI | 2006 | Community-acquired pneumonia and acid-suppressive drugs | Position Paper | View/Download |
Upper GI | 2008 | NSAIDs | Guideline | View/Download |
Upper GI | 2008 | Hip Fracture and PPI Therapy, 2008 | Position Paper | View/Download |
Upper GI | 2010 | Non-Variceal Upper GI Bleeding (adults) 2010 | Guideline | View/Download |
Upper GI | 2010 | PPI and Clopidogrel | Position Paper | View/Download |
Upper GI | 2013 | Hip Fracture and PPI Therapy, 2013 | Position Paper | View/Download |
Upper GI | 2016 | H. pylori (adults), 2016 | Guideline | View/Download |
Upper GI | 2004 | GERD, 2004 | Guideline | View/Download |
Upper GI | 2017 | Dyspepsia | Guideline | View/Download |
Upper GI | 2018 | Esophageal Dysphagia | Guideline | View/Download |
Lower GI | 2019 | Luminal Crohn’s Disease | Guideline | View/Download |
Lower GI | 2019 | Pediatric Crohn’s Disease | Guideline | View/Download |
Endoscopy | 2020 | CAG Advise Regarding COVID-19 and Endoscopy | Position Paper | View/Download |
Upper GI | 2019 | Management of Nonvariceal Upper Gastrointestinal Bleeding | Guideline | View/Download |
Lower GI | 2019 | Management of Bile Acid Diarrhea | Guideline | View/Download |
General | 2022 | Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period | Guideline | View/Download |